Persephone Biosciences

Drug Discovery · San Diego, CA · Founded 2017 · Privately Held (backing)

Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications. Persephone Biosciences is based in San Diego, CA and was founded in 2017. It was valued at $37.3 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $21.6 million across 3 recorded rounds; the latest was a $317,000 seed round in Feb 2021.

PMV mark · valuation
$37.3M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$21.6M
Last round
Seed Round
Feb 2021
What is Persephone Biosciences worth?
$37.3MPrivateMarketView mark · Oct 2026

Valued at $37.3M at its later-stage round, Oct 2024. Nothing has traded since.

Free account
More of Persephone Biosciences with a free account
  • ·The complete investor list: 31 names
  • ·Watch Persephone Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Persephone Biosciences funding history

3 rounds
DateRoundRaisedPost-money
Feb 2021Seed Round$317K▮
Jan 2018Accelerator/Incubator$120K▮
Jul 2017Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

Persephone Biosciences valuation

Persephone Biosciences was valued at $37.3 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Persephone Biosciences raised?

Persephone Biosciences has raised $21.6 million in total; 3 of its rounds are on record, from 2017 on. The largest on record was a $317,000 seed round in Feb 2021.

Persephone Biosciences has filed 1 Form D with the SEC, most recently in Mar 2021 ($317,000 sold to 24 investors).

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Hinge Bio ($46 million), ParcelBio ($41.2 million) and Solarea Bio ($37 million).

How Persephone Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Persephone Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Persephone Biosciences

What is Persephone Biosciences worth?
Persephone Biosciences is valued at $37.3M as of Oct 2026. Valued at $37.3M at its later-stage round, Oct 2024. Nothing has traded since.
How much has Persephone Biosciences raised?
Persephone Biosciences has raised $21.6M in total funding across 3 recorded rounds.
When did Persephone Biosciences last raise?
Persephone Biosciences last raised in Feb 2021 (Seed Round), raising $317K.